Jennifer is an accomplished leader in global clinical development with over 25 years of experience, specializing in the complexities of early-stage drug development within emerging and early-stage biotechnology companies. Currently serving as Senior Vice President of Development Operations at Axonis Therapeutics, Jennifer brings deep expertise in optimizing clinical trials for rare diseases and CNS disorders. Her skill in refining clinical development operations and accelerating development timelines has been pivotal in advancing novel therapies from discovery through to early clinical milestones, underscoring her commitment to addressing unmet medical needs in challenging therapeutic areas.